JSSH
EW icon

J. Safra Sarasin Holding’s Edwards Lifesciences EW Stock Holding History

J. Safra Sarasin Holding’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$949K Sell
11,847
-18,841
-61% -$1.58M 0.01% 404
2026
Q1 		$2.46M Sell
30,688
-1,778
-5% -$147K 0.04% 171
2025
Q4 		$2.77M Buy
32,466
+18,908
+139% +$1.55M 0.05% 172
2025
Q3 		$1.05M Buy
+13,558
New +$1.06M 0.02% 312
2024
Q3 		– Sell
-37,934
Closed -$3.5M – 455
2024
Q2 		$3.5M Buy
+37,934
New +$3.36M 0.06% 162

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

J. Safra Sarasin Holding's EW Position: Q2 2026 in Review

J. Safra Sarasin Holding reduced its Edwards Lifesciences (EW) stake by 61% in Q2 2026, selling an estimated $1.58M and leaving 11,847 shares worth $949K. The position accounts for 0.01% of the portfolio, ranked #404.

J. Safra Sarasin Holding first reported a position in EW in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.5M in Q2 2024. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • J. Safra Sarasin Holding held 11,847 shares of Edwards Lifesciences worth $949K as of Q2 2026.
  • J. Safra Sarasin Holding sold 18,841 Edwards Lifesciences shares in Q2 2026, an estimated $1.58M.
  • Edwards Lifesciences made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #404 holding.
  • J. Safra Sarasin Holding first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 5 quarters since.
  • J. Safra Sarasin Holding's Edwards Lifesciences position peaked at $3.5M in Q2 2024.
  • 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.